We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Hydroxychloroquine Trial Revived by WHO as Doubt Cast on Lancet, NEJM Studies

News   Jun 04, 2020 | by Ruairi J Mackenzie, Science Writer for Technology Networks

 
Hydroxychloroquine Trial Revived by WHO as Doubt Cast on Lancet, NEJM Studies
 
 
Advertisement
 

RELATED ARTICLES

Myelin-Targeting T Cells Found in MS-Mimicking Monkey Disease

News

Scientists have uncovered new clues to the immune infiltration of the brain seen in a central nervous system disease in monkeys that mimics multiple sclerosis.

READ MORE

Tracking AAV Gene Transfer Vector Biodistribution

News

The biodistribution of adeno-associated virus (AAV) gene transfer vectors can be measured in nonhuman primates using a new method. The method quantifies whole-body and organ-specific AAV capsids from 1 to 72 hours after administration.

READ MORE

Designer Cytokine Helps Paralyzed Mice Walk Again

News

Using gene therapy, a research team has succeeded for the first time in getting mice to walk again after a complete cross-sectional injury. The nerve cells produced the curative protein themselves.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE